Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Aging causes skin stem cells to work less effectively.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Finasteride may cause long-lasting sexual side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

DHT may increase the risk of heart disease and death in elderly men.

The document concludes that the hair cycle is a complex process involving growth, regression, and rest phases, regulated by various molecular signals.

5% minoxidil foam once daily works as well as 2% minoxidil solution twice daily for female hair growth and is more convenient.